Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19–9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies

BACKGROUND: Because of the high malignant degree of pancreatic cancer (PC), the early diagnosis of PC is of great concern. Macrophage inhibitory cytokine-1 (MIC-1) was reported to be a potential diagnostic biomarker, but its diagnostic value is indeterminate. Therefore, we performed this meta-analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying, Yan, Shirong, Tian, Hui, Bao, Yixi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851718/
https://www.ncbi.nlm.nih.gov/pubmed/29489701
http://dx.doi.org/10.1097/MD.0000000000009994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851718/
https://www.ncbi.nlm.nih.gov/pubmed/29489701
http://dx.doi.org/10.1097/MD.0000000000009994

Ejemplares similares